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Abstract
Objectives:  Sternotomy  for  cardiac  surgeries  causes  signiﬁcant  postoperative  pain  and  when
not properly  managed  may  cause  signiﬁcant  morbidity.  As  neuropathic  pain  is  a  signiﬁcant
component  here,  gabapentin  and  pregabalin  may  be  effective  in  these  patients  and  may  reduce
postoperative  opioid  consumption.  The  purpose  of  this  systematic  review  was  to  ﬁnd  out  efﬁcacy
of gabapentin  and  pregabalin  in  acute  postoperative  pain  after  cardiac  surgery.
Methods:  Published  prospective  human  randomized  clinical  trials,  which  compared  pre-
operative  and/or  postoperative  gabapentin/pregabalin  with  placebo  or  no  treatment  for
postoperative  pain  management  after  cardiac  surgery  has  been  included  in  this  review.
Results:  Four  RCTs  each  for  gabapentin  and  pregabalin  have  been  included  in  this  systematic
review. Three  gabapentin  and  two  pregabalin  studies  reported  decrease  in  opioid  consumption
in cardiac  surgical  patients  while  one  gabapentin  and  two  pregabalin  studies  did  not.  Three
RCTs each  for  gabapentin  and  pregabalin  reported  lower  pain  scores  both  during  activity  and
rest. The  drugs  are  not  associated  with  any  signiﬁcant  complications.
Conclusion:  Despite  lower  pain  scores  in  the  postoperative  period,  there  is  insufﬁcient  evidence
to recommend  routine  use  of  gabapentin  and  pregabalin  to  reduce  opioid  consumption  in  the
cardiac surgical  patients.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
PALAVRAS-CHAVE Gabapentina  e  pregabalina  no  período  perioperatório  em  cirurgia  cardíaca:  uma
Cirurgia  cardíaca; revisão  sistemática  e  metanálise
 para  cirurgias  cardíacas  causa  dor  intensa  no  pós-operatório  eGabapentina;
Pregabalina;
Dor  no  pós-operatório
Resumo
Objetivos:  A  esternotomiaPlease  cite  this  article  in  press  as:  Maitra  S,  et  al.  Perioperative  gabapentin  and  pregabalin  in  cardiac  surgery:  a  systematic
review  and  meta-analysis.  Rev  Bras  Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2016.07.014
quando não  tratada  adequadamente  pode  causar  morbidade  grave.  Como  nesse  caso  a  dor
neuropática  é  uma  componente  importante,  gabapentina  e  pregabalina  podem  ser  eﬁcazes
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nesses  pacientes  e  podem  reduzir  o  consumo  de  opiáceos  no  pós-operatório.  O  objetivo  desta
revisão sistemática  foi  avaliar  a  eﬁcácia  de  gabapentina  e  pregabalina  na  dor  aguda  após  cirurgia
cardíaca.
Métodos: Estudos  clínicos  prospectivos  e  randômicos  com  humanos,  que  compararam  o  uso
de gabapentina/pregabalina  nos  períodos  pré-  e/ou  pós-operatório  com  placebo  ou  nenhum
tratamento  para  o  controle  da  dor  no  pós-operatório  de  cirurgia  cardíaca  foram  incluídos  nesta
revisão.
Resultados:  Quatro  ECRs  de  gabapentina  e  pregabalina  foram  incluídos  nesta  revisão  sis-
temática.  Três  estudos  de  gabapentina  e  dois  de  pregabalina  relataram  diminuic¸ão  do  consumo
de opiáceos  em  pacientes  cirúrgicos  cardíacos;  um  estudo  de  gabapentina  e  dois  de  prega-
balina não  relataram.  Três  ECTs  de  gabapentina  e  pregabalina  relataram  escores  menores  de
dor, durante  a  atividade  e  o  repouso.  Os  medicamentos  não  estão  associados  a  complicac¸ões
signiﬁcativas.
Conclusão: :  Embora  os  escores  de  dor  tenham  sido  menores  no  pós-operatório,  não  há  evidên-
cias suﬁcientes  para  recomendar  o  uso  rotineiro  de  gabapentina  e  pregabalina  para  reduzir  o
consumo de  opiáceos  em  pacientes  cirúrgicos  cardíacos.
© 2016  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este e´  um
artigo Open  Access  sob  uma  licenc¸a  CC  BY-NC-ND  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Date  source  and  search  methodntroduction
ternotomy  for  cardiac  surgery  causes  signiﬁcant  postopera-
ive  pain,1 which  has  both  signiﬁcant  short  term  and  long
erm  consequences.  Poorly  managed  acute  postoperative
ain  may  complicate  immediate  postoperative  period2,3 and
ay  also  cause  chronic  pain.4 Though  patients  usually  feel
orst  pain  in  the  ﬁrst  postoperative  day,  signiﬁcant  pain  may
ontinue  up  to  sixth  postoperative  day.5 Adequately  man-
ged  acute  pain  lowers  the  myocardial  oxygen  demand  and
ecreases  the  incidence  of  ischemic  episodes.3,6 Parenteral
pioids,  though  effective,  may  cause  sedation,  respiratory
epression,  nausea-vomiting  and  pruritus  which  may  be
roublesome.7 Moreover,  opioids  may  have  limited  efﬁcacy
hen  pain  is  associated  with  activity  such  as  coughing  and
eep  breathing.8 Options  of  central  neuraxial  analgesia  in
ardiac  surgical  population  is  also  limited  mostly  because  of
erioperative  anticoagulant  use,  and  its  superiority  to  PCA
pioid  is  also  debatable.9
Acute  postoperative  pain  may  also  have  a  signiﬁcant
europathic  component  along  with  nociceptive  pain  due
o  peripheral  mechanoreceptor  stimulation  and  both  cen-
ral  and  peripheral  sensitization  by  several  mechanisms.10,11
uring  sternotomy,  intercostal  nerves  may  be  damaged  by
tretching  of  the  intercostal  nerves  at  the  costo-vertebral
unction  due  to  sternal  retraction  and  damage  may  also
ccur  during  dissection  of  internal  mammary  artery  from  the
ternum;  all  of  which  ultimately  contribute  to  neuropathic
ain.
The  gabapentinoids  gabapentin  and  pregabalin  are  novel
ntiepileptic  drugs,  which  also  have  signiﬁcant  efﬁcacy
n  neuropathic  pain12,13 and  postoperative  pain.14--16 They
xert  anti-nociceptive  effect  by  binding  with  the  2
ubunit  of  voltage  sensitive  calcium  channel.14,17 As  well  as
aving  a  central  anti-allodynic  effect  they  also  inhibit  pain
ransmission.17 The  drugs  are  available  only  as  oralPlease  cite  this  article  in  press  as:  Maitra  S,  et  al.  Perioperative  
review  and  meta-analysis.  Rev  Bras  Anestesiol.  2016.  http://d
reparations,  and  differ  mainly  in  bioavailability.
abapentin  is  absorbed  in  the  duodenum  by  a  saturable
-amino  acid  transport  mechanism,  so  that  bioavailability
W
Paries  inversely  with  dose.18 Bioavailability  also  varies
idely  between  individuals  underlining  the  need  for  dose
ndividualization  to  achieve  clinical  goals.19 In  contrast,
regabalin  is  absorbed  throughout  the  small  intestines  with
inear  uptake  without  transporter  saturation.17 Both  the
rugs  have  very  low  plasma  protein  binding,  no  metabolism
nd  is  excreted  unchanged  in  urine;  dose  modiﬁcation  is
eeded  in  renal  impairment.17 With  an  elimination  half-life
f  4.8--8.7  h,  gabapentin  requires  thrice  daily  dosing.18
ltered  formulations  have  been  devised  to  facilitate  once
r  twice  daily  regimens,  e.g.  Gralise  (sustained  release)
nd  gabapentin  enacarbil  (a  prodrug).20 Pregabalin  has  an
limination  half-life  of  5.5--6.3  h,  requiring  twice  to  thrice
aily  dosing.17 Both  are  free  from  signiﬁcant  side  effects
nd  drug  interactions  in  the  clinically  useful  dosage.17
abapentin  may  be  useful  for  the  prevention  of  chronic
ostsurgical  pain  also.21 Both  have  also  been  extensively
tudied  in  various  surgical  population  for  postoperative  pain
anagement  with  varying  degrees  of  success.  Few  RCTs22--29
ave  addressed  the  efﬁcacy  of  perioperative  administration
f  gabapentinoids  on  acute  postoperative  pain  after  cardiac
urgery  and  they  reported  variable  results.  Hence,  we
onducted  this  systematic  review  to  ﬁnd  out  efﬁcacy  of
abapentin  and  pregabalin  in  acute  postoperative  pain
fter  cardiac  surgery.
ethods
ublished  prospective  human  clinical  trials,  which  compared
reoperative  and/or  postoperative  gabapentin/pregabalin
ith  placebo  or  no  treatment  for  postoperative  pain  man-
gement  after  cardiac  surgery  has  been  included  in  this
eview.gabapentin  and  pregabalin  in  cardiac  surgery:  a  systematic
x.doi.org/10.1016/j.bjane.2016.07.014
e  did  an  electronic  search  in  the  following  database:
ubMed,  PubMed  Central,  EMBASE  and  CENTRAL  with  the
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PRISMA 2009 Flow diagram
Records identified through
database searching
(n=174)
Records screened
(n=174)
Full-text articles assessed
for eligibility
(n=10)
Studies included in
qualitative synthesis
(n=8 )
Studies included in
quantitative synthesis
(meta-analysis)
(n=8)
Records excluded
(n=164 )
n=2 of full-text articles
excluded:
n=1 article compared
gabapentin with diclofenac
for chronic pain
n=1 article was non-RCT
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Keywords:  ‘‘gabapentin’’;  ‘‘pregabalin’’;  ‘‘cardiac’’  and
‘‘sternotomy’’  to  ﬁnd  out  the  eligible  clinical  trials  on  20th
September  2013.  Another  literature  search  was  also  done
on  9th  August;  2015  to  update  the  result  of  the  previous
search.  The  search  strategy  in  PubMed  has  been  men-
tioned  in  Appendix  1.  References  from  the  primary  search
results  were  also  manually  searched  for  potentially  eligible
trials.
Study  selection
Published  prospective  randomized  human  clinical  tri-
als,  which  compared  preoperative  and/or  postoperative
gabapentin/pregabalin  with  placebo  or  no  treatment  for
postoperative  pain  management  after  cardiac  surgery  have
been  included  in  this  study.  We  did  not  impose  any  lan-
guage  restriction  in  the  search  strategy.  Studies  that  have
been  done  on  either  adult  or  pediatric  population  have  beenPlease  cite  this  article  in  press  as:  Maitra  S,  et  al.  Perioperative  
review  and  meta-analysis.  Rev  Bras  Anestesiol.  2016.  http://dx
included  in  this  review.  We  did  not  search  for  unpublished
trials.  Authors  were  not  asked  for  unpublished  data  in  the
included  trials.  A  PRISMA  ﬂow  diagram30 of  study  selection
is  depicted  in  Fig.  1.
D
T
Nam  for  study  selection.
xclusion  criteria
linical  trials  where  oral  gabapentin  or  pregabalin  has  been
ompared  with  placebo  or  any  other  drug  in  surgical  popu-
ations  other  than  cardiac  surgery  were  not  included  in  this
eview.  Studies  which  did  not  report  the  effects  of  the  study
rug  on  acute  postoperative  pain  were  also  excluded.  We
lso  excluded  studies  where  a postoperative  regional  anal-
esia  technique  was  used  as  a  part  of  multimodal  regimen.
ata  collection
otentially  eligible  trials  were  manually  searched  from  the
bstracts  to  determine  their  eligibility  in  this  review.  We  col-
ected  the  required  data  from  the  full-text  of  the  trials.  Two
uthors  independently  (DKB,  SB)  extracted  all  data  from  the
ligible  trials.  Initially  all  data  were  tabulated  in  Microsoft
xcelTM spread  sheet.gabapentin  and  pregabalin  in  cardiac  surgery:  a  systematic
.doi.org/10.1016/j.bjane.2016.07.014
ata  items
he  following  data  were  extracted  from  the  eligible  trials:
ame  of  the  ﬁrst  author,  year  of  publication,  methods  of
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andomization  and  blinding,  study  population,  protocol  of
tudy  drug  administration,  postoperative  opioid  consump-
ion  and  pain  scores,  incidence  of  chronic  pain  following
ternotomy  and  chronic  pain  scores,  duration  of  mechani-
al  ventilation  and  ICU  stay,  and  adverse  reactions.  All  the
xtracted  data  were  tabulated  in  a  Microsoft  Excel  spread-
heet.
Primary  outcome  measure  of  this  review  was  postop-
rative  pain  scores  (both  at  rest  and  dynamic).  Secondary
utcome  measures  were  postoperative  opioid  consumption,
ffects  of  the  study  drugs  on  opioid  related  adverse  effects,
uration  of  mechanical  ventilation  and  ICU  stay.
Where  a  quantitative  meta-analysis  was  not  possible  a
ualitative  systemic  review  of  the  reported  data  was  per-
ormed.
isk  of  bias  in  individual  studies
he  quality  of  eligible  trials  was  assessed  using  the  ‘risk
f  bias’  tool  within  Review  Manager,  version  5.2.3  soft-
are  (Review  Manager  [RevMan].  Version  5.2.  Copenhagen:
he  Nordic  Cochrane  Centre,  The  Cochrane  Collabora-
ion,  2012)  by  two  authors  working  independently  (SM  and
S).  Random  sequence  generation,  allocation  concealment,
linding,  incomplete  data,  and  selective  reporting  were
ssessed;  based  on  the  method  of  the  trials,  each  was  graded
‘yes’’,  ‘no’,  or  ‘unclear’,  which  reﬂected  a  high  risk  of  bias,
ow  risk  of  bias,  and  uncertain  bias,  respectively.  Risks  of
ias  summary  in  the  individual  studies  have  been  provided
n  Fig.  2.
esults
atabase  searching  revealed  174  articles.  In  six  clinical
tudies  gabapentin  was  used  as  an  analgesic  in  cardiac  sur-
eries.  However,  in  one31 of  them  it  was  compared  with
iclofenac;  hence  it  was  excluded  from  analysis.  Another
CT32 compared  a  gabapentin  containing  multimodal  reg-
men  with  opioid-based  analgesic  regimen.  Finally,  four
CTs23,25,26,28 evaluating  gabapentin  and  another  four  study-
ng  pregabalin22,24,27,29 met  our  inclusion  criteria  for  this
ystematic  review.  Risk  of  bias  in  the  individual  studies
as  been  furnished  in  Fig.  2.  Study  protocol  of  the  individ-
al  studies  and  patient  population  have  been  described  in
able  1.  The  pooled  results  have  been  summarized  in  the
ollowing  section.
ostoperative  pain
ll  the  included  studies  reported  pain  scores  at  different
oints  of  time;  hence  a  pooled  analysis  has  not  been  possi-
le.
abapentin
cak  et  al.28 reported  a  lower  pain  score  with  the  use  of
abapentin  both  during  rest  and  cough  at  6  h,  12  h,  18  h,  24  h,
8  h  and  72  h.  Soltanzadeh  et  al.26 reported  that  pain  scores,Please  cite  this  article  in  press  as:  Maitra  S,  et  al.  Perioperative  
review  and  meta-analysis.  Rev  Bras  Anestesiol.  2016.  http://d
oth  at  rest  and  during  coughing  at  2  h,  6  h,  and  12  h  after
xtubation  were  signiﬁcantly  lower  in  patients  who  received
abapentin.  Menda  et  al.23 reported  lower  pain  scores
uring  rest  up  to  48  h  after  extubation  but  only  up  to  12  h  for
(
c
a
dFigure  2  Summary  of  ‘‘risk  of  bias’’  at  individual  study
level.
ain  during  coughing.  However,  Rapchuk  et  al.25 reported  a
imilar  VAS  score  both  during  rest  and  coughing  up  to  72  h
ostoperative  period.  Raﬁq  et  al.32 evaluated  pain  scores  by
1  point  NRS  and  found  that  patients  in  the  gabapentin  con-
aining  multimodal  group,  in  all  categories,  except  ‘‘worst
ain’’  on  day  4,  had  lower  mean  pain  scores.  Patients  had
igniﬁcantly  lower  average  pain  sensation  from  day  0  (day
f  surgery)  throughout  to  day  3.  The  least  pain  experienced
uring  the  day  was  also  lower  in  the  multimodal  group  from
ay  1  to  day  3.
regabalin
n the  study  of  Joshi  et  al.22 pain-scores  at  rest  at  6  h,  12  h,
4  h  and  36  h  from  extubation  and  pain  scores  at  deep  breath
t  4  h,  6  h,  12  h,  24  h  and  36  h  from  extubation  were  less
n  pregabalin  treated  patients  (p  <  0.05).  They  also  found
hat  peak  inspiratory  ﬂow  rates  as  assessed  by  incentive
pirometry  were  higher  in  pregabalin  group  as  compared
o  control  group  at  12  h,  24  h  and  36  h  from  extubation
24gabapentin  and  pregabalin  in  cardiac  surgery:  a  systematic
x.doi.org/10.1016/j.bjane.2016.07.014
p  <  0.05).  Pesonen  et  al. reported  signiﬁcantly  lower  per-
entage  of  patients  requiring  analgesia  at  2  h,  10  h  and  12  h
fter  extubation  in  the  pregabalin  group  (p  <  0.05).  Sun-
ar  et  al.27 could  not  detect  any  difference  in  VAS  scores
Please  cite  this  article  in  press  as:  Maitra  S,  et  al.  Perioperative  gabapentin  and  pregabalin  in  cardiac  surgery:  a  systematic
review  and  meta-analysis.  Rev  Bras  Anestesiol.  2016.  http://dx.doi.org/10.1016/j.bjane.2016.07.014
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Table  1  Summary  of  study  protocol  and  results  of  individual  studies.
Author  &  year  Patients  Study  protocol  Post-operative
analgesics
Analgesic  outcome  Other  outcome
Gabapentin
Soltanzadeh  M
et al.,  201126
60  men  aged
20--70  years
posted  for  CABG
Oral  gabapentin
800  mg  2  h  before
surgery  and
400  mg  2  h  after
extubation
(n =  30),  vs.
placebo  (n  =  30)
Morphine  Pain  scores  both  at
rest  and  during
coughing  were
signiﬁcantly  lower
in the  gabapentin
group  (p  =  0.02).
Hemodynamic
changes  (HR,  SBP,
DBP)  and  the
incidence  of
nausea,  vomiting
and  respiratory
depression  within
24  h  were
comparable
between  the  two
groups.
Postoperative
mechanical  ventilation
was  signiﬁcantly
(p  =  0.03)  longer
(5.4  ±  1.7  h)  in
gabapentin  than  in
control  group
(4.4  ±  1.6  h).
The  number  of
over-sedated  patients
(a  sedation  score  >  2)
was  higher  in
gabapentin  group.
Menda et  al.,
201023
60  young  men
undergoing  CABG
Oral  gabapentin
600  mg  2  h  before
surgery  (n  =  30),
vs.  placebo
(n  =  30)
Morphine  PCA,
paracetamol
Total  morphine
consumption  was
lower  in  the  GABA
group  (6.7  ±  2.5)
than  the  placebo
(PLA)  group
(15.5  ±  4.6  mg,
p <  0.01)  at  24  h.
Pain  scores  at  rest
were  signiﬁcantly
lower  in  the  GABA
group  throughout
the  study  period
(p  <  0.05).
Pain  scores  at  2,  6,
and  12  h  during
coughing  were
signiﬁcantly  lower
in the  GABA  group
(p <  0.05),  whereas
pain  scores  during
coughing  were
similar  at  18,  24,
and 48  h  between
the  groups.
The  postoperative
mechanical  ventilation
period  was  signiﬁcantly
prolonged  in  the  GABA
group  (6.6  ±  1.2  h)
compared  with  the  PLA
group  (5.5  ±  1  h,
p  <  0.01).
The  number  of  over
sedated  patients
(patients  with  a
Ramsay  score  >  2)  was
higher  in  the
GABA  group  at  2,  6,
and  12  h  of  study.
There  was  lower
incidence  of  nausea  in
the  GABA  group
(p  =  0.02).
Rapchuk
et al.,  201025
60  patients
undergoing
median
sternotomy
Oral  gabapentin
1200  mg  2  h  before
surgical  incision
and  600  mg  twice
a  day  for  the  next
two  postoperative
days  (n  =  30),  vs.
placebo  (n  =  30).
Fentanyl  PCA,
paracetamol,
tramadol,
pethidine,
NSAIDs
Total  PCA  fentanyl
usage  in  the  ﬁrst
48  h  was  similar  in
two  groups.
VAS  scores  recorded
at  12,  24,  48  and
72  h  at  rest  and
movement  were  not
signiﬁcantly
different.
Sleep  scores,  number
of  antiemetic  doses  in
ﬁrst  48  h,  adjunctive
pain  medications  used
and score  achieved  on
the  quality  of  recovery
questionnaire  were
similar  in  the  two
groups.
The  incidence  of
side-effects
(arrhythmias,  dizziness
and  sedation)  was  also
similar.
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Table  1  (Continued)
Author  &  year  Patients  Study  protocol  Post-operative
analgesics
Analgesic  outcome  Other  outcome
Ucak  A  et  al.,
201128
40  patients  with
IHD  undergoing
CABG
Oral  gabapentin
1.2  g/dL  1  h  before
surgery  and  for  2
days  after  surgery
(n  =  20),  vs.
placebo  (n  =  20)
Tramadol,
paracetamol
Postoperative  pain
scores  at  1,  2,  and  3
days  were  lower  in
the  gabapentin
group  (p  <  0.05).
Pain  scores  at  1  and
3  months
postoperatively
were  also  lower  in
the  gabapentin
group  (p  >  0.05).
Consumption  of
rescue  analgesic
(tramadol)  within
24  h  after
extubation  in  the
gabapentin  group
was  99.0  ±  53.8  mg
vs.  149.4  ±  72.5  mg
in the  placebo
group  (p  <  0.05).
There  were  no
differences  in  the
incidence  of  side
effects  and  time  to
extubation.
Pregabalin
Joshi et  al.,
201322
40  patients  aged
30--65  years
undergoing
primary  off-pump
CABG
Oral  pregabalin
150  mg  2  h  before
induction  and
75  mg  every  12  h
for  2
post-operative
days  (n  =  20),  vs.
placebo  (n  =  20)
Tramadol,
paracetamol,
diclofenac
Pain-scores  at  rest
at  6,  12,  24  and  36  h
from  extubation  and
pain  scores  at  deep
breath  at  4,  6,  12,
24 and  36  h  from
extubation  were
less  in  pregabalin
treated  patients
(p <  0.05).  Rescue
analgesic  (tramadol)
consumption  was
reduced  by  60%  in
pregabalin  group
(p <  0.001).  The  pain
severity  scores  were
higher  in  the  control
group  at  12,  24  and
36  h  (p  <  0.05).  Pain
at  rest  and  deep
breathing  at  1
month  and  3  months
after  surgery  were
comparable  among
the  groups.
Sedation  (RASS),
incidences  of
respiratory  depression
and  nausea  were
comparable.
Extubation  time,
duration  of  ICU  and
hospital  stay  were  also
similar.  Peak
inspiratory  ﬂow  rates
as  assessed  by
incentive  spirometry
were  higher  in
pregabalin  group  as
compared  to  control
group  at  12,  24  and
36  h  from  extubation
(p <  0.05)
Pesonen
et al.,  201124
70  patients  aged
75  years  or  older,
undergoing
primary  elective
CABG  or  single
valve  repair  or
replacement  with
Oral  pregabalin
150  mg  1  h  before
surgery  and  75  mg
twice  daily  for  5
postoperative  days
(n  =  35),  vs.
placebo  (n  =  35)
Oxycodone  Percentage  of
patients  requiring
analgesia  was
signiﬁcantly  lower
at 2,  10,  and  12  h
after  extubation  in
the  pregabalin
RASS  and  MMSE  scores
were  similar  between
the  groups  and
CAM-ICU  scores  were
signiﬁcantly  lower  in
the  placebo  group  on
the 1st  postoperativePlease  cite  this  article  in  press  as:  Maitra  S,  et  al.  Perioperative  
review  and  meta-analysis.  Rev  Bras  Anestesiol.  2016.  http://d
CPBgabapentin  and  pregabalin  in  cardiac  surgery:  a  systematic
x.doi.org/10.1016/j.bjane.2016.07.014
group  (p  <  0.05). day.
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Table  1  (Continued)
Author  &  year  Patients  Study  protocol  Post-operative
analgesics
Analgesic  outcome  Other  outcome
Pregabalin  also
reduced
consumption  of
parenteral
oxycodone  during
16  h  after
extubation  by  43%
and  total  oxycodone
consumption  from
extubation  to  the
end  of  the  ﬁfth
postoperative  day
by  48%.  The
incidence  of  pain
during  movement
was  signiﬁcantly
lower  in  the
pregabalin  group  at
3 months
postoperatively,  but
pain  after  1  month
was  similar.
Time  to  extubation  was
signiﬁcantly  longer  in
the  pregabalin  group
(638  ±  285  vs.
500  ±  233  min;
p  <  0.05).  Incidence  of
nausea  and  vomiting
was  comparable.
Sundar et  al.,
201227
60  adult  patients
scheduled  for
elective  off-pump
CABG
Oral  pregabalin
150  mg  1  h  before
surgery  (n  =  30),
vs.  placebo
(n  =  30)
Fentanyl  VAS  measured  at  6,
12,  and  24  h  after
surgery  and  fentanyl
consumption  up  to
24  h  after  surgery
was  similar  between
the  groups.
Ramsay  sedation  scores
at 6,  12,  and  24  h  after
surgery  were  similar
between  the  groups.
Duration  of  ventilation
and  ICU  stay  and
incidences  of  nausea,
vomiting  and  dizziness
were  also  comparable.
Ziyaeifard
et al.,  201529
60  patients  older
than  20  years
posted  for  elective
CABG
Oral  pregabalin
150  mg  2  h  before
surgery  (n  =  30),
vs.  placebo
(n  =  30)
Morphine  Pain  scores  were
signiﬁcantly  lower
in the  pregabalin
group  at  4,  12,  and
24 h  of  surgery
(p  <  0.05);  but
morphine
consumption  was
similar  between  the
groups.
Duration  of  ICU  stay
was  similar.
CABG, Coronary Artery Bypass Grafting; HR, Heart Rate; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure; PCA, Patient Controlled
VAS, 
ent
a
o
p
z
r
v
vAnalgesia; IHD, Ischemic Heart Disease; ICU, Intensive Care Unit; 
MMSE, Mini Mental State Examination; CAM-ICU, Confusion Assessm
measured  at  6  h,  12  h,  and  24  h  after  surgery;  while  Ziyaei-
fard  et  al.29 found  pain  scores  to  be  signiﬁcantly  lower  in  the
pregabalin  group  at  4  h,  12  h,  and  24  h  of  surgery  (p  <  0.05).
Postoperative  opioid  consumptionPlease  cite  this  article  in  press  as:  Maitra  S,  et  al.  Perioperative  
review  and  meta-analysis.  Rev  Bras  Anestesiol.  2016.  http://dx
Gabapentin
Three  studies23,26,28 reported  postoperative  opioid  consump-
tion  up  to  24  h  after  extubation  and  one25 reported  fentanyl
consumption  up  to  48  h.  Two23,26 of  them  used  morphine
r
v
s
(Visual Analogue Scale; RASS, Richmond Agitation-Sedation Scale;
 Method for the ICU.
nd  one28 used  tramadol.  Menda  et  al.23 found  that  pre-
perative  gabapentin  reduces  morphine  consumption  than
lacebo  (6.7  ±  2.5  mg  vs.  15.5  ±  4.6  mg,  p  <  0.01).  Soltan-
adeh  et  al.26 reported  pre  and  postoperative  gabapentin
educes  opioid  consumption  than  placebo  (0.9  ±  1.5  mg
s.  1.5  ±  4  mg,  p  =  0.01).  Ucak  et  al.28 reported  intra-
enous  tramadol  consumption  and  found  that  gabapentingabapentin  and  pregabalin  in  cardiac  surgery:  a  systematic
.doi.org/10.1016/j.bjane.2016.07.014
educes  tramadol  consumption  than  placebo  (99  ±  53.8  mg
s.  149.4  ±  72.5  mg,  p  <  0.05).  Rapchuk  et  al.25 reported
imilar  fentanyl  consumption  at  48  h after  extubation
1355  ±  995  mcg  vs.  1562  ±  1056  mcg;  p  =  0.46;  n  =  54).
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Mean difference
IV, Fixed, 95% Cl
Mean difference
IV, Fixed, 95% Cl
Placebo
WeightTotalSDSD MeanMeanStudy or subgroup
Menda et al 2010 6.6
9.6 4.1 27 9.2 3.9 27
30
20
–2 –1 0 1 2
0.8
1.64.4301.7
1.47.9
5.4
20 7.65
3.2%
29.2%
20.9%
0.40 [–1.73, 2.53]
1.00 [0.16, 1,84]
0.25 [–0.46, 0.96]
1.2 30 5.5 1 30 46.7% 1.10 [0.54, 1.66]
Rapchuk et al 2010
Soltanzadeh et al 2011
Ucak et al 2011
Heterogeneity: Chi2=3.79, df=3 (P=.29); l2=21%
Favours [Gabapentin]    Favours [Placebo]Test for overall effect: Z=4.15 (P<.0001)
Total (95% Cl) 107 107 100.0% 0.81 [0.43, 1.19]
Total
Gabapentin
Figure  3  Forest  plot  showing  pooled  analysis  of  mean  difference  of  duration  of  mechanical  ventilation  for  gabapentin.
Mean difference
IV, Random, 95% Cl
Mean difference
IV, Random, 95% Cl
Control
WeightTotalSDSD MeanMeanStudy or subgroup
Joshi et al 2013 7.45
10.63 4.75 29 8.33 3.88 31
30
–100 –50 0 50 100
5.1310.37304.6810.6
28.2%
24.4%
2.30 [0.10, 4.50]
0.23 [–2.25, 2.71]
1.95 20 7.68 1.98 20 47.4% –0.23 [–1.45, 0.99]
Pesonen et al 2011
Sundar et al 2012
Heterogeneity: Tau2=0.91, Chi2=3.89, df=2 (P=.14); l2=49%
Favours [experimental]    Favours [control]Test for overall effect: Z=0.76 (P=.45)
Total (95% Cl) 79 81 100.0% 0.60 [–0.94, 2.13]
Total
Pregabalin
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regabalin
oshi  et  al.22 found  that  tramadol  consumption  was  reduced
y  60%  in  the  pregabalin  group  compared  to  placebo
67.8  ±  60.25  mg  vs.  167.1  ±  52.1  mg,  p  <  0.001).  Pesonen
t  al.24 reported  that  pregabalin  reduced  consumption
f  parenteral  oxycodone  during  16  h  after  extubation  by
3%  (8  ±  5  mg  vs.  14  ±  6  mg,  p  <  0.001)  and  total  oxy-
odone  consumption  from  extubation  to  the  end  of  the
fth  postoperative  day  by  48%  (48  ±  28  mg  vs.  93  ±  44  mg,
 <  0.001).  However,  Sundar  et  al.27 and  Ziyaeifard  et  al.29
ound  no  difference  in  fentanyl  (241.67  ±  178.87  mcg  vs.
51.67  ±  181.47  mcg,  p  >  0.05)  and  morphine  (3  ±  0.17  mg
s.  3.1  ±  0.15  mg,  p  >  0.05)  consumption  up  to  24  h  after
urgery  respectively.  Of  note,  pregabalin  was  continued  in
he  postoperative  period  in  the  ﬁrst  two  RCTs  (till  days  2  and
 respectively),22,24 and  was  used  as  a  single  preoperative
ose  in  the  last  two.27,29
hronic  pain
abapentin
cak  et  al.28 found  that  pain  scores  at  1  and  3  months  post-
peratively  were  lower  in  the  gabapentin  group  but  the
ifference  was  not  statistically  signiﬁcant  (p  >  0.05).
regabalin
n  the  study  by  Joshi  et  al.22 pain  at  rest  and  deep  breath-
ng  at  1  month  and  3  months  after  surgery  were  comparable
mong  the  groups.  Pesonen  et  al.24 reported  that  the  inci-
ence  of  pain  during  movement  was  signiﬁcantly  lower  in
he  pregabalin  group  at  3  months  postoperatively,  but  pain
fter  1  month  was  similar.
uration  of  mechanical  ventilationPlease  cite  this  article  in  press  as:  Maitra  S,  et  al.  Perioperative  
review  and  meta-analysis.  Rev  Bras  Anestesiol.  2016.  http://d
 pooled  analysis  found  that  duration  of  mechanical  ven-
ilation  is  signiﬁcantly  increased  with  the  use  gabapentin
MD  =  0.81  h;  95%  CI  0.43--1.19;  p  <  0.0001;  n  =  214)  (Fig.  3)
f
O
i
snce  of  duration  of  mechanical  ventilation  for  pregabalin.
ut  not  with  pregabalin  (MD  =  0.60  h;  95%  CI  −0.94--2.13;
 = 0.45;  n  =  160)  (Fig.  4).
ength  of  ICU  stay
se  of  perioperative  gabapentin  (MD  =  1.06  h;  95%  CI
0.67--2.79;  p  =  0.23;  n  =  120)  or  pregabalin  (MD  = 0.63  h;
5%  CI  −3.59--4.85;  p  =  0.77;  n  =  220)  does  not  affect  the
uration  of  ICU  stay  signiﬁcantly.
ostoperative  complications
abapentin
ommonly  reported  adverse  effects  of  gabapentin  are  seda-
ion,  dizziness  and  somnolence.17 Ucak  et  al.28 reported
o  increased  incidence  of  any  of  the  adverse  effects  of
abapentin.  Menda  et  al.23 reported  an  increased  inci-
ence  of  sedation  (Ramsay  sedation  score  >  2)  with  the
se  of  gabapentin  at  2  h,  6  h  and  12  h  after  extubation.
hey  also  reported  a  signiﬁcantly  less  incidence  of  nau-
ea  in  gabapentin  treated  patients.  Rapchuk  et  al.25 and
oltanzadeh  et  al.26 also  reported  no  increased  adverse
ffect  with  the  use  of  gabapentin.
regabalin
regabalin  has  a  side  effect  proﬁle  similar  to  that
f  gabapentin.17 Sedation  scores  and  incidence  of  nau-
ea/vomiting  as  reported  by  three  RCTs22,24,27 were
omparable  between  groups.  Joshi  et  al.22 also  reported  sim-
lar  incidence  of  respiratory  depression  and  Sundar  et  al.27gabapentin  and  pregabalin  in  cardiac  surgery:  a  systematic
x.doi.org/10.1016/j.bjane.2016.07.014
ound  similar  occurrence  of  dizziness  between  the  groups.
n  the  other  hand,  CAM-ICU  scores  were  signiﬁcantly  lower
n  the  placebo  group  on  the  1st  postoperative  day  in  the
tudy  of  Pesonen  et  al.24
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Discussion
The  principal  ﬁndings  of  this  review  are  that  gabapentin
did  not  reduce  postoperative  opioid  consumption  after  car-
diac  surgery;  but  may  reduce  pain  scores  at  the  expense
of  increased  duration  of  mechanical  ventilation.  However,
gabapentin  was  safe  and  free  of  serious  adverse  effects  and  a
single  study23 reported  decreased  incidence  of  nausea  also.
Pregabalin,  on  the  other  hand,  decreased  postoperative  pain
scores;  reduced  opioid  consumption  when  it  was  continued
in  the  postoperative  period;  and  did  not  increase  duration
of  mechanical  ventilation,  sedation  or  other  side  effects.
Efﬁcacy  of  perioperative  gabapentin  in  reducing  pain  is
well  established  in  other  surgeries  like  spine  surgeries,33
breast  surgeries,34 gynecologic  surgeries35 etc.  However,  it
may  not  have  efﬁcacy  in  management  of  post  craniotomy
pain.36 It  is  likely  that  gabapentin  will  be  more  effective
where  neuropathic  component  is  signiﬁcant.  Futility  of  sin-
gle  preoperative  dose  of  gabapentin  has  been  found  in
various  settings.37--39 Gabapentin  may  be  more  effective  in
postoperative  pain  management  at  higher  doses  and  when
administered  both  pre  and  postoperatively.17 Amongst  the
included  studies  in  our  review,  Ucak  et  al.28 and  Rapchuk
et  al.25 used  gabapentin  at  a  dose  of  1200  mg/day  2 h  before
surgery  and  continued  in  the  postoperative  period  also.  How-
ever,  Menda  et  al.23 used  only  in  the  preoperative  period
and  Soltanzadeh  et  al.26 used  a  lower  dose  of  gabapentin
(800  mg/day).  It  is  notable  that  despite  using  gabapentin
at  a  dose  of  1200  mcg/day  both  pre  and  postoperatively,
Rapchuk  et  al.25 did  not  ﬁnd  any  reduction  of  pain  scores
and  fentanyl  consumption.  Parlow  et  al.40 in  2010  found  that
plasma  concentration  of  gabapentin  is  unaffected  by  cardio-
pulmonary  bypass  and  patients  who  received  gabapentin
consume  similar  amount  of  morphine  in  the  postoperative
period  as  those  who  did  not.  In  previous  studies,41 where
gabapentin  was  found  to  be  ineffective,  use  of  regional  anes-
thesia  in  those  studies  was  blamed  and  a  speculation  was
made  that  regional  anesthesia  could  have  prevented  cen-
tral  sensitization.  However,  none  of  the  studies  included
here  used  any  regional  anesthesia  technique.  From  a  clinical
point  of  view,  a  reduced  opioid  requirement  may  be  more
important  than  only  pain  scores.  Again  pain  scores  recorded
at  speciﬁc  time  points  only  does  not  imply  patients’  analge-
sia  over  a  time  period.  None  of  the  studies  reported  patients’
satisfaction  level  here.
Data  reporting  chronic  pain  was  inadequate  for  any
conclusion.
Efﬁcacy  of  pregabalin  in  reducing  post-operative  acute
pain  has  been  reviewed  in  several  meta-analyses.15,42,43 Eipe
et  al.15 came  to  the  conclusion  that  pregabalin  decreases
analgesic  consumption  following  various  types  of  surger-
ies,  but  had  a  small  effect  in  improving  pain  control
and  this  effect  is  primarily  observed  in  surgeries  asso-
ciated  with  pronociceptive  mechanisms,  e.g.  spine,  joint
arthroplasty,  and  amputations.  As  sternotomy  and  sternal
retraction  involves  intercostal  nerve  damage  and  associ-
ated  central  and  peripheral  sensitization,  acute  allodynia
and  hyperalgesia  often  occur.10 This  may  explain  the  ﬁnd-
ing  of  reduced  pain  scores  with  pregabalin  in  three  ofPlease  cite  this  article  in  press  as:  Maitra  S,  et  al.  Perioperative  
review  and  meta-analysis.  Rev  Bras  Anestesiol.  2016.  http://dx
the  included  RCTs.22,24,29 Two  RCTs22,24 which  had  continued
pregabalin  150  mg/day  in  the  postoperative  period,  demon-
strated  reduced  opioid  consumption,  whereas  the  other  two
A
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CTs27,29 using  single  preoperative  150  mg  dose  of  pregabalin
id  not  ﬁnd  any  reduction.  In  the  case  of  Sundar  et  al.,27
heir  study  was  not  adequately  powered  to  detect  differ-
nces  in  pain  scores  or  opioid  consumption.  The  absence
f  effect  in  the  other  one29 corroborates  the  conclusion  of
chmidt  et  al.17 that  continuing  the  drug  postoperatively
s  likely  to  be  more  effective  than  a  single  preoperative
ose,  though  it  is  in  contrast  to  the  ﬁnding  by  Mishriky
t  al.  in  their  meta-analysis.42 Mishriky  et  al.42 had  found
o  signiﬁcant  difference  between  single  and  multiple  dos-
ng  regimens,  but  their  analysis  had  a  signiﬁcant  component
f  heterogeneity  because  of  pooling  of  different  surgeries
nd  anesthesia  techniques.  This  contradiction  calls  for  fur-
her  research  in  this  area.  However,  it  should  be  noted  that
he  effect  of  cardio-pulmonary  bypass  on  pregabalin  has
ot  been  studied.  In  at  least  one  study,22 improved  anal-
esia  translated  into  improved  peak  inspiratory  ﬂow  rates
s  assessed  by  incentive  spirometry.
Increased  duration  of  mechanical  ventilation  after
abapentin  use  may  be  due  to  a  well-known  side  effect
f  gabapentin  i.e.  increased  sedation.  However,  the  incre-
ent  is  clinically  insigniﬁcant:  mean  difference  is  only  0.81  h
48  min).  It  is  to  be  kept  in  mind  that  the  studies  used  dif-
erent  extubation  and  weaning  protocol  and  this  result  is  to
e  interpreted  cautiously.  Pregabalin  did  not  increase  dura-
ion  of  mechanical  ventilation.  Both  drugs  did  not  have  any
ffect  on  the  duration  of  ICU  stay.
Despite  popular  belief,  gabapentin  was  shown  to  increase
edation  in  one  RCT  only.  None  of  the  studies  reported
ny  serious  adverse  effects  of  gabapentin.  Moreover,  one
tudy23 found  that  gabapentin  may  reduce  postoperative
ausea  also.  It  is  not  surprising,  because  it  may  have  similar
fﬁcacy  after  craniotomy  also.36 A  lower  morphine  require-
ent  in  gabapentin  treated  patients  may  be  responsible  for
his.  Incidences  of  sedation,  respiratory  depression  and  nau-
ea/vomiting  were  not  altered  with  pregabalin  as  well.  This
ack  of  signiﬁcant  side  effects  may  be  explained  by  the  use
f  a  lower  dose  (150  mg)  of  the  drug.
The  clinical  relevance  of  our  review  is  that  in  spite  of
mall  individual  studies  reporting  beneﬁt  of  using  perioper-
tive  gabapentinoids  in  cardiac  surgery,  our  analysis  failed
o  corroborate  any  unambiguous  clinical  efﬁcacy,  though
o  signiﬁcant  adverse  effect  is  associated.  So,  there  is  no
trong  evidence  to  support  using  perioperative  gabapentin
nd  pregabalin  in  cardiac  surgical  patients  at  this  time.
imitations
he  most  important  limitation  of  our  review  is  the  inclusion
f  limited  number  of  studies.  Despite  extensive  database
earching,  only  eight  studies  could  be  included.  Individual
tudies,  though  well  designed,  comprise  small  number  of
atients.  A  large  RCT  in  the  future  may  alter  our  ﬁnding.  The
osage  protocols  of  gabapentin  and  pregabalin  are  also  var-
ed  in  the  studies.  Data  on  chronic  pain  is  also  very  limited.gabapentin  and  pregabalin  in  cardiac  surgery:  a  systematic
.doi.org/10.1016/j.bjane.2016.07.014
t  this  time  there  is  insufﬁcient  evidence  to  recommend
outine  use  of  gabapentin  and  pregabalin  to  reduce  opioid
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onsumption  in  the  cardiac  surgical  patients  primarily  for
he  management  of  acute  postoperative  pain.
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ppendix 1.
‘‘gabapentin’’  [Supplementary  Concept]  OR  ‘‘gabapentin’’
All  Fields])  AND  (‘‘heart’’[MeSH  Terms]  OR  ‘‘heart’’  [All
ields]  OR  ‘‘cardiac’’  [All  Fields])
(‘‘gabapentin’’  [Supplementary  Concept]  OR
‘gabapentin’’  [All  Fields])  AND  (‘‘sternotomy’’  [MeSH
erms]  OR  ‘‘sternotomy’’  [All  Fields])
(‘‘pregabalin’’  [Supplementary  Concept]  OR
‘pregabalin’’  [All  Fields])  AND  (‘‘heart’’  [MeSH  Terms]  OR
‘heart’’  [All  Fields]  OR  ‘‘cardiac’’  [All  Fields])
(‘‘pregabalin’’  [Supplementary  Concept]  OR
‘pregabalin’’  [All  Fields])  AND  (‘‘sternotomy’’  [MeSH
erms]  OR  ‘‘sternotomy’’  [All  Fields])
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